COMT polymorphism in development of levodopa-induced dyskinesia in Korean Parkinson's disease patients: Case control study of 178 patients based on genetic predictors in Parkinson's disease progression (GEPIP) cohort.

被引:0
|
作者
Park, Sea Mi
Lee, Myoung Chong
Cho, A-Hyun
Lim, Jiyoung
Song, Kyuyoung
机构
[1] Univ Ulsan, Asan Med Coll, Dept Biochem & Mol Biol, Ulsan 680749, South Korea
[2] Univ Ulsan, Asan Med Coll, Dept Neurol, Ulsan 680749, South Korea
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:643 / 643
页数:1
相关论文
共 50 条
  • [1] COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson's disease
    Akhmadeeva, G.
    Khidiyatova, I.
    Gilyazova, I.
    Umutbaev, S.
    Kachemaeva, O.
    Baitimerov, A.
    Galimova, R.
    Magzhanov, R.
    MOVEMENT DISORDERS, 2022, 37 : S560 - S561
  • [2] Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease
    Ivanova, S. A.
    Alifirova, V. M.
    Freidin, M. B.
    Pozhidaev, I. V.
    Fedorenko, O. Y.
    Bokhan, N. A.
    Zhukova, I. A.
    Zhukova, N. G.
    Wilffert, B.
    Loonen, A. J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1039 - S1040
  • [3] Catechol-O-methytransferase enzyme gene polymorphism (COMT RS 6267) play a role in susceptibility in Parkinson's disease and levodopa induced dyskinesia: Genetic predictors in Parkinson's disease progression (GEPIP) chort study
    Park, Sea-Mi
    Cho, A-hyun
    Lee, Myoung-Chong
    Lim, Jiyoung
    Song, Kyuyoung
    ANNALS OF NEUROLOGY, 2006, 60 : S73 - S73
  • [4] Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study
    Choudhury, Supriyo
    Pradhan, Richeek
    Paul, Pritikanta
    Das, Manisha
    Gupta, Anupam
    Ghosh, Pahari
    Chatterjee, Suparna
    NEUROLOGICAL RESEARCH, 2014, 36 (09) : 841 - 846
  • [5] Levodopa-induced dyskinesia in Parkinson's disease
    Brotchie, JM
    Lee, J
    Venderova, K
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (03) : 359 - 391
  • [6] Levodopa-induced dyskinesia in Parkinson’s disease
    J. M. Brotchie
    J. Lee
    K. Venderova
    Journal of Neural Transmission, 2005, 112 : 359 - 391
  • [7] Effect of Safinamide on Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
    Bhatt, Mohit
    Chirileanu, Dana
    Meshram, Chandrashekhar
    Stanzione, Paolo
    Forrest, Emma C.
    NEUROLOGY, 2010, 74 (09) : A319 - A319
  • [8] Risk factors for levodopa-induced dyskinesia in Parkinson's disease patients
    Djuric, Gordana
    Markovic, Vladana
    Pekmezovic, Tatjana
    Tomic, Aleksandra
    Kresojevic, Nikola
    Kostic, Vladimir
    Svetel, Marina
    VOJNOSANITETSKI PREGLED, 2017, 74 (10) : 921 - 926
  • [9] Pridopidine for the treatment of Levodopa-induced Dyskinesia in patients with Parkinson's disease
    Geva, M.
    McGarry, A.
    Cohen, Y.
    Johnston, T.
    de Somer, M.
    Kieburtz, K.
    Hayden, M.
    Brotchie, J.
    Olanow, C.
    MOVEMENT DISORDERS, 2020, 35 : S396 - S396
  • [10] Chemical management of levodopa-induced dyskinesia in Parkinson's disease patients
    Dragasevic-Miskovic, Natasa
    Petrovic, Igor
    Stankovic, Iva
    Kostic, Vladimir S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 219 - 230